David Stern

David Stern Email and Phone Number

Chief Executive Officer @ Kindbody
Boston, MA, US
David Stern's Location
Greater Boston, United States, United States
David Stern's Contact Details

David Stern personal email

n/a
About David Stern

As Chief Executive Officer executed the sale of an Orbimed/F-Prime backed commercialization stage company. Full P&L and leadership responsibility for $1.2 billion global business franchise with sales operations in 90+ countries. Accelerated sales revenues, delivered double digit growth and expanded operations in Japan, China and other International markets. Built go-to-market commercial business plans for three development stage startup companies and launched first products in US and International markets. Successful track record in launching new products and turning around lagging brands and teams in established biopharmaceutical markets.  As CEO, successfully sold commercial stage, venture backed company to Lupin Pharmaceuticals Proven success in launching pharmaceutical and biotech products into new and existing markets. Global and US management experience in building and directing high performance R&D and commercial teams. Demonstrated ability leading commercial teams to exceed sales and profit targets. Named one of 100 most influential people in the Pharmaceutical Industry by PharmaVoice Recognized as one of the top 30 Emerging Leader (under 45) in the Pharmaceutical Industry by Pharmaceutical Executive.

David Stern's Current Company Details
Kindbody

Kindbody

View
Chief Executive Officer
Boston, MA, US
Website:
kindbody.com
Employees:
635
David Stern Work Experience Details
  • Kindbody
    Chief Executive Officer
    Kindbody
    Boston, Ma, Us
    View
  • Digital Data Design (D^3) Institute At Harvard
    Business Mentor
    Digital Data Design (D^3) Institute At Harvard Sep 2024 - Present
    From Lab to Launch, the AI Lab for Startups at D^3 helps Harvard academic-led innovations accelerate to have meaningful global impact. We accept only the most promising projects - teams that have deep technical expertise in their fields, commercializing new ventures born from research with AI/ML at the core of their innovation.
    View
  • Freya Biosciences
    Member Board Of Directors
    Freya Biosciences Jun 2024 - Present
    Freya Biosciences is a trans-Atlantic biotech company specializing in women's health. With a focus on reproductive microbial immunotherapy interventions, Freya aims to improve fertility outcomes and empower women with innovative solutions.
    View
  • Alliance For Fertility Preservation
    Board Member
    Alliance For Fertility Preservation Mar 2024 - Present
    Lafayette, California, Us
    View
  • Moncap
    Advisor
    Moncap May 2023 - Present
    Boulder, Colorado, Us
    View
  • Boston Ivf
    Chief Executive Officer
    Boston Ivf Jan 2020 - Present
    Waltham, Massachusetts, Us
    View
  • Opal Kramer Consulting
    Consultant
    Opal Kramer Consulting 2015 - Present
    Provide commercialization strategy and business operational support to several well respected pharma/biotech/life science organizations/startups. Specializing in marketing strategy, managed care access differentiation, key opinion leader development, business development and strategy, clinical trial design for label claims, and market analysis.
  • Ohana Biosciences, Inc.
    Chief Commercial And Global Corporate Development Officer
    Ohana Biosciences, Inc. Sep 2018 - Mar 2019
    Cambridge, Massachusetts, Us
    View
  • California Cryobank
    Member Board Of Directors
    California Cryobank Oct 2015 - Oct 2018
    Los Angeles, Ca, Us
    California Cryobank is the leading provider of reproductive and stem cell services in the United States. California Cryobank was sold to GI Partners in 2018. Provide strategic guidance for company on long term goals; set annual, 3 year revenue and EBITA targets.  Chair of compensation committee. Approve all executive salaries and bonus plans. Assist in company growth through international opportunities and M&A strategy.
    View
  • Symbiomix Therapeutics, Llc
    Chief Executive Officer
    Symbiomix Therapeutics, Llc Feb 2017 - Mar 2018
    Symbiomix Therapeutics was an Orbimed/F-Prime Capital Partners backed biopharmaceutical company that brought innovative medicines to market for prevalent gynecologic infections that can have serious health consequences. Solosec, the company's first drug was approved by the FDA as the first and only single dose treatment for bacterial vaginosis in September 2017. Successfully sold Symbiomix to Lupin Pharmaceuticals in October 2017 Build capabilities for commercial launch of SolosecTM to OBGYNs in the US. Identify third party logistics partner; license company in 31 states; negotiate wholesaler contracts; develop market access strategy; contract with managed care organizations. Responsible for corporate strategy and business planning, capital structure and fundraising, business development strategy, Phase 4, lifecycle management and pipeline development. Present at financial conferences, secure funding, and meet with potential investors.  Board member and facilitator of quarterly Board of Managers meetings; ensure alignment between board and company management.
  • Celmatix
    Chief Commercial Officer
    Celmatix Oct 2014 - Sep 2016
    New York, Ny, Us
    Celmatix is a privately held precision medicine company focused on maximizing lifelong female fertility. I am responsible for developing and executing the company’s go-to-market strategies for Polaris, the world's first analytics platform that helps fertility doctors create personalized treatment plans designed to maximize a woman's fertility, among other products. Develop launch strategy for positioning and messaging, marketing, sales pricing and business model of Polaris US launch. Identify, develop, and build research continuum of Key Opinion Leaders within the Fertility Industry to compile clinical experience. Assemble commercial team consisting of sales, marketing and customer support for launch. Develop and execute strategy for the annual European Society of Human Reproductive Endocrinology and American Society of Reproductive Medicine congresses.  Identify thought leaders and develop relationships with advisory board members. Member of Celmatix executive team, guiding long term strategy development.
    View
  • Ovascience
    Executive Vice President, Global Commercial Operations
    Ovascience Feb 2014 - Sep 2014
    Head of Global Commercial, preparing to launch new innovative fertility treatment to help improve egg quality for women that have failed multiple IVF cycles or have poor egg quality.Develop global strategy and launch company’s first commercial treatment. Create launch strategy for positioning and messaging, marketing, sales, and go-to-market distribution. Launch first commercial treatment, AUGMENT, in four regions outside of the US. Identify and initiate Center of Excellence model of Key Opinion Leaders within Fertility Industry to compile clinical experience. Build commercial team consisting of sales, marketing and medical personnel. Develop and execute global strategy for the annual global congresses.  Member of OvaScience executive team, participating in long term strategy development.
  • Merck Serono
    Senior Vice President, Head Of Global Business Franchise, Fertility
    Merck Serono Apr 2012 - Feb 2014
    Darmstadt, Hessen, De
    Maximize long-term franchise value and ensure business sustainability. Head of Global Franchise Team comprised of Regional Business Franchise Leaders, Top 10 country Business Unit Heads (EU5, US, China, Japan, Australia, Russia), Business Development, Portfolio Management, Medical Affairs, R&D, Business Intelligence, Finance, and Manufacturing. Responsible for short, mid and long term strategic development and growth of $1 Billion Global Fertility Portfolio consisting of 7 global brands.  Shape the Global Franchise Strategy and develop global ten-year Strategic Plan for long term Franchise sales and P&L.  Build pipeline through collaborative external research model. Developed new R&D model with external partners to create 19 new projects for “high speed” clinical validation of new technologies to improve overall patient outcomes. Lead Business Development in acquiring new technologies for vertical integration into Assisted Reproductive Technologies. o Closed deal with Auxogyn to provide strategic, medical, and commercial support for launch of Eeva™ Embryo Diagnostic Test.
    View
  • Emd Serono Inc.
    Executive Vice President, Endocrinology
    Emd Serono Inc. Aug 2006 - Apr 2012
    Boston, Massachusetts, Us
    Head of Commercial US Operations for Fertility, Growth Hormone, and HIV Responsible for US Commercial Operations for EMD Serono Core Product Portfolio in Reproductive Health and Metabolic Endocrinology. Full P&L responsibility, demonstrated ability to drive revenue while maintaining high margins.o Gonal-f®, Ovidrel®, Luveris®, Cetrotide®,– Reproductive Portfolioo Egrifta®, Saizen®, Serostim®, Zorbtive® – Metabolic Endocrinology Built a commercial infrastructure that turned lagging Fertility business around, gained back $50M of lost sales revenue, grew share by 7% in 2007, 13.5% in 2008.  Gonal-f named 2007 Brand of the Year.  Serostim named 2008 Brand of the Year following 3rd year in a row of surpassing revenue & unit growth targets in HIV. Lead and motivate a business unit with 130 professionals to deliver double-digit top-line revenue growth while managing expenses to generate positive margins. Oversee partner relationship with development partner, Theratechnologies in launching new drug class for HIV Lipodystrophy in US market, EGRIFTA®. Present quarterly to US President, Global COO and Global CEO.  Member of the US Senior Team.
    View
  • Emd Serono Inc.
    Evp, Metabolic Endocrinology
    Emd Serono Inc. Dec 2005 - Aug 2006
    Boston, Massachusetts, Us
    Responsible for the commercial operations of the Metabolic Endocrinology Business Unit in the US, Including Marketing, Medical, Sales, Business Development.
    View
  • Emd Serono Inc.
    Vp, Marketing
    Emd Serono Inc. Aug 2003 - Nov 2005
    Boston, Massachusetts, Us
    View
  • Organon
    Director Of Reproductive Marketing
    Organon 2000 - 2003
    Jersey City, Nj, Us
     Create strategy and manage launch of the first Direct-To-Consumer campaign, NuvaRing. Total revenue of Therapeutic area - $350 million (2002). P&L responsibility for $58 million dollar marketing budget for Women’s Health Franchise.  Responsible for Business Development for Women’s Health Portfolio including in-license, co-marketing, and out-license agreements.
    View

David Stern Skills

Product Launches Pharmaceutical Sales Pharmaceuticals Product Launch Strategic Planning Medical Devices Marketing Strategy Strategy Development Biotechnology People Management Pharmaceutical Industry Marketing Oncology Management Pharmaceutics Business Development Sales Effectiveness Program Management Start Ups Strategy Leadership Crm Endocrinology Market Research Medicine Biopharmaceuticals Market Access Customer Relationship Management Clinical Development Commercialization Reproductive Endocrinology Managed Care International Marketing

David Stern Education Details

  • Babson F.W. Olin Graduate School Of Business
    Babson F.W. Olin Graduate School Of Business
    International Marketing And Management
  • Brandeis University
    Brandeis University
    Biology And Economics
  • Akiba
    Akiba

Frequently Asked Questions about David Stern

What company does David Stern work for?

David Stern works for Kindbody

What is David Stern's role at the current company?

David Stern's current role is Chief Executive Officer.

What is David Stern's email address?

David Stern's email address is ds****@****mix.com

What schools did David Stern attend?

David Stern attended Babson F.w. Olin Graduate School Of Business, Brandeis University, Akiba.

What are some of David Stern's interests?

David Stern has interest in Children.

What skills is David Stern known for?

David Stern has skills like Product Launches, Pharmaceutical Sales, Pharmaceuticals, Product Launch, Strategic Planning, Medical Devices, Marketing Strategy, Strategy Development, Biotechnology, People Management, Pharmaceutical Industry, Marketing.

Who are David Stern's colleagues?

David Stern's colleagues are Rebecca Gordon, Fams-Llc -Kam, Shanita Mikes-Marr, Katerina Jones, Desiree Crawford, Paul Magarelli, Kaci Rogers.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.